Cibus Inc is a biotechnology company focused on developing and commercializing innovative crop-enhancement solutions for the agricultural sector. Utilizing its proprietary technology platform, the company aims to improve crop yields and resilience by creating products that harness the power of gene editing. Cibus works closely with farmers and agricultural partners to provide sustainable solutions that address the challenges of modern farming, such as pest resistance and climate adaptability. Through its commitment to advancing agricultural productivity, Cibus strives to contribute to food security and promote environmentally friendly practices in agriculture. Read More
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering of 13,333,333 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), at a public offering price of $1.50 per share (the “Offering”). Members of Cibus’ Board of Directors will purchase 1,000,000 shares of Class A Common Stock in the Offering at the public offering price.
SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share (“Class A Common Stock”), in an underwritten public offering (the “Offering”). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A Common Stock offered in the Offering on the same terms and conditions. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed or as to the actual size or terms of the Offering. Members of Cibus’ Board of Directors (collectively, the “Related Persons”) have indicated an interest in purchasing shares of Class A Common Stock in the Offering. Because these indications of interest are not binding agreements or commitments to purchase, those certain Related Persons may elect not to purchase any shares in the Offering, or the underwriter may elect not to sell any shares in the Offering to those certain Related Persons.
Nonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, Central America and the Caribbean
Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus’ plans to bring improved traits to European growers
Cibus (CBUS) Q3 2025 results show a narrower loss but a revenue miss, sending shares lower. The company highlights progress on key rice traits and cost-saving initiatives.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue
SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report third quarter 2025 financial results on Thursday, November 13, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.
Collaboration aims to accelerate the adoption of advanced gene editing technologies in and deliver high-performance traits that support more sustainable and productive rice production in India
Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability solutions to farmers
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City.
Cibus and Centro Internacional de Agricultura Tropical (CIAT) have entered into an agreement to introduce Cibus’ proprietary herbicide tolerance trait into elite rice germplasm for Latin America
Cibus Inc (CBUS) reports Q2 2025 earnings with revenue missing estimates at $930K but a narrower loss of -$0.61 per share. Progress in gene-edited crops and cost cuts offer optimism.
Streamlining operational focus on Rice herbicide tolerance traits and partner-funded and/or supported programs, expected to reduce annual cash usage to approximately $30 million by 2026
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2025 financial results on Thursday, August 14, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.
